These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The index and improvement effect of using Danhong injection to patients with atherosclerosis symptoms of coronary heart disease (CHD). Sun K; Fu C; Nie S; You Y Pak J Pharm Sci; 2014 Sep; 27(5 Suppl):1699-704. PubMed ID: 25262522 [TBL] [Abstract][Full Text] [Related]
50. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies. Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788 [TBL] [Abstract][Full Text] [Related]
51. Variability of biomarkers in patients with chronic heart failure and healthy controls. Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733 [TBL] [Abstract][Full Text] [Related]
52. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes. Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558 [TBL] [Abstract][Full Text] [Related]
53. Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kabłak-Ziembicka A; Przewłocki T; Stępień E; Pieniążek P; Rzeźnik D; Sliwiak D; Komar M; Tracz W; Podolec P Kardiol Pol; 2011; 69(10):1024-31. PubMed ID: 22006602 [TBL] [Abstract][Full Text] [Related]
54. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score. Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476 [TBL] [Abstract][Full Text] [Related]
55. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study. Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413 [TBL] [Abstract][Full Text] [Related]
56. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors. Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356 [TBL] [Abstract][Full Text] [Related]
57. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation]. Yin D; Huang J; Feng L; Feng GX; Hu SS Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993 [TBL] [Abstract][Full Text] [Related]
58. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion. Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740 [TBL] [Abstract][Full Text] [Related]
59. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
60. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction. Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]